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ABSTRACT
xICEFFECTS
LATE DEFLATION STUDY: E G
OF IAB TIMING IN HUMANS
by
Manal Morcos
Conventional IABP timing deflates 100% of the balloon volume before the onset of left
ventricular ejection and has been well established in the literature as a safe and effective
method. Yet, recent studies suggest that deflation of the IAB at or near the onset of
systole improve myocardial efficiency (Kern, 1999, 1129). To test whether deflation of
the IAB at a later deflation time reduces left ventricular workload and enhances coronary
perfusion, four timing methods were evaluated in 20 patients: T1 (100% IAB volume
deflated before onset of ejection), T2 (60% IAB volume deflated before and 40% volume
during ejection), T3 (25% IAB volume deflated before and 75% volume during ejection)
and T4 (100% deflation simultaneous with left ventricular ejection).
To identify an optimal timing point for the deflation of the IAB, data was analyzed.
Data analysis consisted of three main parts: elimination of files containing noise artifact,
normalization of data for ease of analysis, and correction for variations in mean aortic
pressure and heart rate which take into account the dynamic state of the heart. Late IAB
deflation at 50% of the volume deflated prior to left ventricular ejection produced
significantly greater percentage changes in systolic pressure time index (SPTI), diastolic
pressure time index (DPTI), the SPTI/DPTI ratio, systemic vascular resistance (SVR) as
compared to conventional timing, T1. No significant change in heart rate or cardiac
output was established.
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CHAPTER 1
•

PHYSIOLOGICAL BACKGROUND RELEVANT TO IAB
COUNTERPUL SATION
1.1

Introduction: Heart Failure and Intra-Aortic Balloon Pump Therapy

In the United States, nearly 2.3 million individuals are affected with chronic heart failure.
Each year, approximately 400,000 people develop heart failure, and "this number is
likely to increase as greater numbers of patients who might have died of an acute
myocardial infarction are surviving, but with compromised ventricular function" (Quaal
1993, 41). This disorder is the cause of 1,000 deaths each day and now represents the
most common medical discharge diagnosis for patients over the age of 65 years.
In a general population study conducted by Kannel, heart failure was found to be
greater in men than in women due to a higher incidence of coronary artery disease.
Within six years of diagnosis, the mortality rate was 82% for men and 67% for women,
corresponding to a mortality rate that is four to eight times greater than that of the general
population for the same age group. Sudden death occurred to a greater degree in men
than in women with an incidence of 28% versus 14% respectively.
"HF is not a specific disease, but rather the inability of the heart to pump blood
commensurate with body tissue metabolic needs. Delivery of oxygen becomes
inadequate, leading to cellular dysfunction and imminent organ failure" (Quaal 1993, 43).
Deterioration and impairment of cardiac function is a result of a decline in cardiac output
and systemic blood flow. Braunwald described heart failure as a secondary occurrence to
a massive MI (myocardial infarction), sudden onset of tachyrhthmia, or bradyrhythmia.
He further explains that when the heart is subjected to pressure or volume overload for a
long duration, a more gradual but progressive state of heart failure may occur.
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Heart failure can occur one of two ways: inadequate emptying of the venous
reservoirs (backward failure) or reduced ejection of blood under pressure into the aorta
and pulmonary artery (forward failure). These two cases are not fully independent,
however, because the circulatory system is a closed system (i.e. blood flows in a circle).
Therefore, if failure in the ventricle causes a reduction in ejection, then filling will also be
reduced and vice versa.
The intra-aortic balloon pump (IABP) has become a useful method for providing
temporary mechanical support to those patients diagnosed with heart failure. Downing,
et al cited that the single largest groups of patients who benefit from IABP support
consist of cardiac surgical patients in whom IABP support has been instituted
intraoperatively. Several applications of IABP support that have been suggested but
considered controversial include: acute myocardial ischemia or unstable angina, left main
coronary artery disease, postinfarction ventricular septa' defect, acute cardiogenic shock,
hemorrhagic shock, septic shock, intractable ventricular tachyarrhythmias, and major
noncardiac operations in patients with severe left ventricular dysfunction (Downing 1981,
112).
In this 7-year study, it was concluded that high complication rates sustained by
IABP patients appear to be related to the "severity of underlying disease than to technical
features of IABP counterpulsation per se". Therefore, follow-up after 2 years from
discharge of patients given IABP support showed that survival rate was 45+3% but the
functional status of the surviving patients was markedly improved (90% of survivors in
New York Heart Association Class I or II).
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Another study conducted by Arafa et al suggested that although there was no
association between IAB-related complications and death, the average mortality rate over
a ten-year period of 344 patients undergoing cardiac operations and who required the use
of IABP support was 53% (Arafa 1998, 745). This percentage is consistent with other
studies that report mortality rates between 36% and 61% of patients undergoing cardiac
operations including those experiencing cardiogenic shock (references cited on page 745
of this article). Survival rates are at a higher rate if the IABP is inserted prophylactically
"before operation in high-risk patients with unstable angina, left main coronary artery
stenosis, and left ventricular dysfunction". Yet, this study confirmed the results of
Downing's research that hospital survivors usually had a relatively good probability of
late survival (see Figure 1 below). Although the mortality rates discussed above are high
for patients who received IABP support, "the long term prognosis was relatively good for
patients who survived the early postoperative period" (Arafa 1998, 746).

Figure 1: (Source: Arafa)

From these two studies, it is evident that the use of intra-aortic balloon pump
therapy for assisting the failing heart can reduce the mortality rate and is critical to saving
thousands of lives each.year. In order for the reader to understand this importance, it is
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essential to gain a fundamental basis for the heart by examining the physiological
background relevant to the heart in a healthy state. In other words, "essential to an
understanding of physiological benefits derived from intra-aortic balloon
counterpulsation (IABC) is a foundation of normal cardiac anatomy and physiology"
(Quaal 1993, 3). Thus, it is the intent of this chapter to provide the necessary foundation
to fully understand and appreciate the benefits of IABC discussed in subsequent chapters.
Although intra-aortic balloon pump therapy is employed when the left ventricle
fails to provide an adequate pumping effort, this chapter will not concentrate on
characteristics and function of the left ventricle as a single entity. The interaction
between the left ventricle with other muscular chambers of the heart and with the
circulatory system as a whole is significant because the consequence of such an
interaction provides the essential nutrients to all aspects of the human body. Therefore,
the general properties of the heart will be noted prior to focus on the subject at hand-the
left ventricle.

1.2 Background
1.2.1 Gross Anatomy of the Human Heart
The human heart is a hollow muscular organ positioned in the thoracic cavity midline
between the sternum (breastbone) and the vertebrae (backbone), specifically between the
third and sixth ribs. Barely the size of a clenched fist of the individual in whom it
resides, the heart measures 12 to 13 cm from base to apex and 7 to 8 cm at its widest
point, weighing about .474% of the individual's body weight (approximately 0.75 lb.).
Serving as the center of the cardiovascular system, it is considered a "vital pipeline for
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transporting materials on which the cells of the body are absolutely dependent"
(Sherwood 1997, 266). The heart serves as a pump that imparts pressure to the blood to
establish adequate pressure gradients necessary for blood to flow to the tissues.
The muscular wall of the heart is divided into three parts: the epicardium, the
myocardium, and the endocardium. The outer surface of the heart is covered by the
epicardium, a thin, transparent layer, continuous with the pericardium at the base of the
heart. The ventricular myocardium lies between the epicardium and the endocardium
The heart is enclosed and held in place within the thorax by a tough connective tissue sac,
the pericardium, which maintains the heart's position while still allowing the free
movement of the heart during vigorous beating (Fried 1990, 573).
The heart is divided by the interatrial-interventricular septum into a crescentshaped right side and a cylindrically shaped left side, each side being as a pump that
together are connected in series. The heart is composed of four muscular chambers that
collectively serve the role of a double pump to deliver oxygenated blood from the lungs
to the rest of the body and deoxygenated blood from the body back to the lungs. The two
upper chambers are the right and left atria, and the two lower chambers are the right and
left ventricles.
The degree of musculature of each of the chamber walls is a function of pressure
gradients encountered during the pumping state of the heart. The atria' s muscular
chambers are thin walled, the thinness of their walls is appropriate due to the low
pressures normally developed in the atrial cavities (Katz 1992, 6). The ventricles develop
much higher pressures than the atria, and therefore, have thicker muscular walls.
However, the muscular walls of the right and left ventricles are not equivalent in
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thickness in which the left ventricle has three times the mass and twice the thickness of
the right ventricle (Katz 1992, 2).
The thickness of the ventricles can also be appreciated by comparing the work
demands of each. Work required of the right ventricle is modest compared to the
demands placed on the left ventricle. The pulmonary bed offers little resistance to right
ventricular contraction while, in contrast, the left ventricle is required to generate high
pressure to overcome systemic circulation resistance and eject blood through the aortic
valve and to all aspects of the body. The output of the left ventricle is distributed
throughout systemic circulation, a series of parallel pathways that consists of muscles,
kidneys, the digestive tract, brain, and all other organs (Katz 1992, 6; Quaal 1993, 6;
Sherwood 1997, 268).
Blood flows in a unidirectional fashion from veins to atria to ventricles to arteries
through the presence of four one-way valves. The valves open and close in a similar
manner to that of the atria and ventricles. A greater pressure (forward pressure gradient)
behind the valve will cause the valve to open whereas a greater pressure (backward
pressure gradient) in front of the valve will force the valve to "Close. Located between the
atrium and ventricle in each half of the heart are atrioventricular valves, which permit
blood flow from the atrium to the ventricle but not from the ventricle to atrium as shown
in Figure 2 (Katz 1992, 3). The right AV valve is termed the tricuspid valve (three cusps
or leaflets) while the left is the mitral or bicuspid valve (two cusps or leaflets). The two
remaining heart valves, the semilunar ("half-moon") valves are the aortic and pulmonary
valves located at the juncture between the left ventricle and major arteries (Sherwood
1997, 270).
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1.2.2 Circulation
Blood flow is a direct result of the contraction of the cardiac muscle cells in two
dimensions, thus wringing blood out of the heart. Blood travels through a series of
complex pathways called the cardiovascular system (Figure 2).

Figure 2: (Source: Sherwood)

The role of the right atrium is to receive dark red, oxygen poor blood from
systemic circulation through three veins: the superior vena cava, the inferior vena cava,
and the coronary sinus. Blood from the upper part of the body and the upper limbs (parts
of the body superior to the heart) travels to the right atrium via the superior vena cava.
Blood from the lower part of the body and the lower limbs (parts of the body inferior to
the heart) travels via the inferior vena cava and finally, the coronary sinus brings blood
from most of the vessels supplying the wall of the heart. Direction of flow occurs

8

passively from the right atrium through the tricuspid valve into the right ventricle. The
right ventricle ejects blood into the pulmonary bed with little resistance whereby the
exchange of carbon dioxide and oxygen takes place.
The oxygenated blood returns to the heart, namely the left atrium, via four
pulmonary veins, through the mitral valve, and into the left ventricle. Most of ventricular
filling occurs passively but an additional 20% occurs during atrial contraction. Finally,
the ventricle pumps blood into the ascending aorta where it is transported to all aspects of
the body.

1.2.3 Heartbeat Coordination
Although the heart is innervated by the autonomic nervous system, it can contract and
relax without any direct stimulus from the nervous system. The cardiac tissue possess the
properties of automaticity (ability to initiate an electrical impulse), conductivity (ability
to conduct an electrical impulse), rhythmicity (regularity of the pacemaking activity)
(Katz 1992, 473; Sherwood 1997, 274).
The heart has its own intrinsic regulating system called the conduction system
which is composed of specialized muscle tissue that generates and distributes the
electrical impulse that stimulate the cardiac muscle fibers to contract. These tissues are
the sinoatrial (SA) node, atrioventricular (AV) node, the atrioventricular bundle, the
bundle branches, and the Purkinje fibers, which, like all myocardial cells, are selfexcitable and able to rhythmically generate action potentials. This activity is recorded
using the electrocardiogram, a scalar quantity that consists of three clearly recognizable
waves: the P wave, the QRS complex, and the T wave (Figure 3).
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Figure 3: (Source: Katz)

In a healthy human heart, a heartbeat is a two-phase process as follows: atria
contract while the ventricles relax, and then the atria relax while the ventricle contract.
Thus, a complete mechanical cardiac cycle (one heartbeat) corresponds to these two
phases, each portion defined as systole (contraction or propulsion of blood) or diastole
(relaxation or filling of blood) depending on the particular function being performed by
the heart. The mechanical cardiac cycle is represented as eight divisions of the aortic
pressure waveform, which is known as the Wiggers diagram (section 1.2.5.2).

1.2.4 Electrical Events of the Cardiac Cycle and the Electrocardiogram
The electrocardiogram is primarily a tool for evaluating the electrical events within
the heart and is used as a trigger for Intra-aortic balloon counterpulsation. The
manifestation of these events represents "the sum of the action potentials occurring
simultaneously in many individual cells and can be detected by recording electrodes at
the surface of the skin" (Vander 1994, 415).
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Contraction of myocardial cells is triggered by initial depolarization of group of
conducting-system cells, the SA node, located in the right atrium' near the entrance of the
superior vena cava. The SA node is considered the primary pacemaker of the heart
because of its characteristic of having the fastest discharge rate of any of the myocardial
cells with pacemaker activity. "Its depolarization normally generates the current that
leads to depolarization of all other cardiac-muscle cells, and so its discharge rate
determines the heart rate, the number of times the heart contracts per minute" (Vander
1994, 413).
The wave of depolarization that originates in the SA node spreads into the right
atrium and then to the left atrium. The time for the wave of depolarization to travel over
the atria is reflected as the first deflection in the electrocardiogram, the P wave (Figure
3). It is important to realize at this point, that the depolarization of the SA node is not
visible in the ECG because the "SA node is too small to generate electrical potential
differences great enough to be recorded from the body surface" (Katz 1992, 482).
After the occurrence of the P wave, the ECG returns to its baseline because the
electrical potentials that follow are no longer recorded at the body surface prior to
ventricular depolarization (QRS complex). This interval, the P-R interval, is noted as the
time when wave of depolarization is propagated through the AV (atrioventricular) node,
the AV bundle (also called His bundle or common bundle) and bundle branches.
The second deflection as evidenced in the ECG is the QRS complex, occurring
approximately 0.15 seconds later, and is the result of ventricular depolarization. The
complexity of this deflection is due to both the paths taken by the wave of depolarization
through the thick ventricular walls and the change in current direction in body fluids
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accordingly. Therefore, the form of the complex itself varies from instant to instant and
the absence of the Q and/or S portions may result. Since the R portion is always present
in ECG recordings, it is the wave of choice for triggering of intra-aortic balloon
counterpulsation (see Chapter 2).
Comparison of the P wave to the QRS complex shows that the amplitude of the
QRS complex is greater than that of the P wave, yet, the duration of the complex is about
the same as that of the P wave. The difference in amplitude is due to the fact that
ventricular mass is greater than that of the atria while the similarity in duration can be
explained by the presence of the Purkinje network in the ventricle that causes rapid
propagation of the wave depolarization (Figure 3). Following the QRS complex, the
ECG returns once again to its baseline where the final deflection, the T wave, occurs.
The T wave, normally rounded and unsymmetrical, represents ventricular repolarization.
Occasionally, a small wave with the same polarity as the T wave is visible in the
electrocardiogram. The source of this wave, the U wave, is uncertain but it has been
hypothesized to represent the repolarization of the papillary muscles or the Purkinje
system (Katz; Sherwood; Vander).
In addition to the presence of the major waves listed above, ECG segment
intervals, measured between deflections (P, Q, R, S, and T), are used for clinical
diagnosis. The P-R interval already discussed, is a measure of the time taken by the
impulse to travel from the SA node to the ventricular muscle fibers. The Q-T interval,
measured from the beginning of the QRS complex to the end of the T-wave, is the total
duration of ventricular systole. The S-T interval, measured from the end of the S wave to
the beginning of the T-wave, is the time between the end of the spread of the impulse
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throughout the ventricles and the repolarization of the ventricles (Vander; Sherwood;
Katz).

1.2.5 Mechanical Events of the Cardiac Cycle
1.2.5.1 Mechanics of the Left Ventricle: The left ventricle is governed by changes in
the physical state that ultimately, determine the cardiac output to systemic circulation.
This section will discuss the mechanics of the left ventricle in terms of pressure and
volume changes. The relationship of pressure and volume is critical to application of
counterpulsation techniques to the diseased heart, which will be the topic of Chapter 2.
When the left ventricle is in the filling phase, the volume of blood in that
chamber increases even when intraventricular pressure remains constant. This increase in
volume leads to dilation of the ventricle to consequently, an increase in tension on each
muscle fiber in the ventricular walls. In the diseased heart, higher tensions in the
endocardial region of the ventricle makes the region vulnerable to a reduction in coronary
flow. Thus, to reduce tension in the muscle fibers, an increase in wall thickness
developed during systole is required. This is accomplished by simply distributing tension
among a greater number of active sarcomeres in the overloaded heart. Distribution of
tension can be accomplished by the utilization of an Intra-Aortic Balloon Pump, which
distributes this tension during the inflation phase of the catheter (Chapter 2). The
variables discussed above define the Laplace Law:
where

T = stress or force exerted across an area
P pressure

R = radius
h = wall thickness
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The Laplace Law is significant because understanding the relationships between
left ventricular physical variables in a healthy heart can lead to understanding its
application in a heart that is diseased. For example, it is evident from the equation above
that increase in the diameter of the ventricle will also increase tension or stress. In
congestive heart failure, the dilation of the heart to increase the radius factor not only
causes a decrease in coronary flow (ejection of blood is inadequate), but can result in a
dilation throughout the contractile cycle, and both end-diastolic and end-systolic tensions
are higher (Opie 1998, 362). Katz explains that a decrease in coronary flow can result in
a "greater vulnerability of the endocardium to an imbalance between energy demands and
energy supply. This is due to the fact that the coronary arteries penetrate the ventricles
from the epicardium, and so must traverse a greater distance of contracting myocardium
before they can supply the endocardial portion of the ventricles" (355).
In a healthy heart, the contraction of the heart during the systolic phase requires
energy. Transfer of metabolic energy to ventricular pressure causes an increase in
tension, which consequently, is affected by ventricular volume. Displacement of
ventricular volume during contraction is defined as cardiac work. Hence, cardiac work is
the addition of external and internal work involved in the transfer of energy from its
metabolic substrate to the pressure developed in contraction (Quaal 1993, 37). Internal
work is defined as the energy dissipated in the form of heat or used to govern the opening
or closing of valve cusps. External work is the work done by the left ventricle and is
reflected in a "Work Diagram" or "PV Loop" (Katz 1992, 358; Opie 1998, 365; Quaal
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1993, 38). This diagram illustrates the principle of left ventricular work by relating
ventricular pressure and volume to the cardiac cycle (Figure 4).

Figure 4: (Source: Quaal)

Preload and afterload determine ventricular pressure and volume. The concept of
preload, also known as the Frank-Starling law of the heart, suggests that ventricular fiber
length before contraction (fiber stretch caused by end-diastolic volume) determines the
strength of the contraction that ensues. Therefore, an increase in end-diastolic volume in
the ventricle will result in a greater contractile effort due to the stretching of the cardiac
fibers (Quaal 1993, 11). Afterload is defined as resistance to left ventricular ejection. This
impedance, for the left ventricle, reflects both peripheral resistance and compliance of the
aorta. Aortic impedance is encountered when the left ventricle must overcome aortic enddiastolic pressure to push open the aortic valve during isovolumic contraction (Quaal
1993, 13). During this isovolumic phase, the heart works against the afterload and thus
consumes about 90% of myocardial oxygen. Due to this fact, one of the goals of balloon
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counterpulsation is to reduce the aortic end-diastolic pressure and, thus, reduce
myocardial oxygen consumption.
The Pressure-Volume Loop diagram shown above illustrates the work performed
by the left ventricle. The sequence of events that follow portray the cardiac cycle as it
pertains to that ventricle and it will thus, give aid in understanding the conventional
method of counterpulsation encountered in Chapter 2. The reader is referred to the books
written by Katz, Quaal, and Opie for a more in-depth look at this topic.
The diagram, moving in a counterclockwise direction, is divided into four phases.
The first phase, isovolumic contraction, defines the period when pressure begins to rise
with constant volume caused by the development of tension within the walls of the left
ventricle. Rising pressure causes the mitral valve to close and blood can neither enter nor
leave until the aortic valve opens. The pressure build-up at this time is end-diastolic
pressure.
The second phase, systole defines the period when left ventricular pressure
exceeds aortic pressure and causes aortic valve to open. At the onset of aortic valve
opening, ejection begins. Aortic pressure at this time rises suddenly as blood rushes in
and then falls because the blood travels to systemic circulation. Tension in the walls of
the left ventricle decreases owing to the Law of Laplace because less volume is present in
the left ventricle during ejection (radius decreases).
The third phase defines beginning of diastole or end-systole and occurs at the end
of ejection. Ventricular myocardium begins to relax and pressure in the aorta exceeds
ventricular pressure which causes the aortic valve to close. Ventricular relaxation "is
unloaded because aortic valve closure, by disconnecting the load (aortic pressure) from
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the relaxing left ventricle, relieves the ventricular myocardium of its afterload during all
subsequent phases of relaxation" (Katz 1992, 360).
Phase number four is the period defined as diastole when pressure in the left
ventricle falls below that of the left atrium, and thus, causes the mitral valve to open. The
filling of the ventricle facilitates preload and prepares it for contraction. The state of the
fully relaxed ventricle is defined at point D, end-diastolic PV relationship, when pressure
and volume have risen gradually to this point.
The importance of understanding the pressure and volume relationships of the left
ventricle is its application toward the alleviation of the diseased heart. As will be seen in
Chapter 2, IABP Counterpulsation is a cardiac assist mechanism that is timed in
synchronization with the cardiac cycle, specifically with the pressure and volume phases
occurring in the left ventricle.

12.5.2 Mechanics of the Aorta in Conjunction with the Left Ventricle: Section

1.2.5.1, although useful in gaining a perception of the mechanics of the left ventricle, it
lacks information on the mechanics of the aorta. The placement of the Intra-Aortic
Balloon occurs in the proximal descending aorta, just below the left subclavian artery.
Therefore, the effectiveness of the balloon is measured by identifying the events of the
patient's cardiac cycle synonymous with the phasically pulsed balloon. In an Intra-Aortic
Balloon Pump display, the left ventricular PV relationship or LV pressure waveform is
not available and the clinician relies on another means of obtaining information. The
diagram that follows, the "Wiggers Diagram", precedes the description on the mechanical
events of the cardiac cycle (Figure 5). This diagram is "now an integral part of modem
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cardiology and must be understood fully by all who wish to know the basis for the
pumping action of the heart" (Katz 1992, 361).

Figure 5: (Source: Katz)

The superimposed curves above summarize the cardiodynamic events, which are
summarized as follows:
At the onset of ventricular systole (I), the pressures in both the atrium and
ventricle are approximately equal and the AV valves are in the act of apposition to one
another. Pressure slowly rises within the left ventricle because both the semilunar valves
and AV valves are closed at this time. The slight rise in pressure leads to the contraction
of the ventricle isovolumically and thus defines the period when pressure rises rapidly (III). The rapid rise in pressure causes a "bulging of both the semilunar and AV valves,
which accounts for the. small positive oscillations in the aorta and atrium during this
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period" (Katz 1992, 361). When pressure in the ventricle exceeds the pressure in the
aorta, the semilunar valves open and as a result, the aorta and ventricle become a
"common cavity" (II). In the figure above, the opening of the semilunar valves at this
time is represented by the close tracking of the aortic and ventricular pressure curves to
each other.
The early moments of ventricular ejection is marked by a volumetric change in
the ventricle because blood rapidly rushes out of the ventricle and into the aorta. In the
figure, this is represented by the rise in pressure of aortic pressure to a summit peak (III)
because the rate at which blood enters the aorta is greater than the rate at which it is
expelled to the arterioles. The end of systole is indicated as a decline in aortic and
ventricular pressures as the rate of ejection diminishes (III-IV). Dr. rigger's further
reduces the period of ejection into two phases: the period at which there is maximum
ejection (II-III), and the period at which there is reduced ejection (III-IV). The period of
diastole (IV) is defined as relaxation of the ventricle and aorta defined in the diagram as a
sharp drop in pressure terminated by the closure of the semilunar valves (V). As left
ventricular pressure declines, intra-atrial pressure rises slowly. The AV valves are once
again opened when a pressure difference is present, specifically, when atrial pressure
exceeds that of the ventricle (VI). Rapid flow of blood occurs at this period (VI-VII) and
continues while the pressures in the atria and ventricle decline together, but the atrial
pressure is slightly higher than the ventricular. "In long cycles, this is followed by a
diastasis phase (VII-VIII), during which ventricular inflow is exceedingly slow, and the
pressure rises very gradually both in the atrium and ventricle" (Katz 1992, 363).
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1.3 Summary
The goal of this chapter was to provide the reader with a brief overview of the mechanics
and physiology of the heart. The concepts presented in this chapter provide a basis for
understanding the interaction of the heart and IABP during therapy and will thus, lead to
the establishment of the objective of this study.
The purpose of this study is to determine the optimal time to deflate the JAB
relative to systole so that left ventricular efficiency is improved to a greater extent than
with conventional timing. Hence, the goals of this study is to apply a method of
analyzing the data that can take into account the dynamic state of the heart as well as
eliminate technical error and motion artifact from the data.
Prior to a discussion of the results obtained from the data analysis, this thesis will
provide the following:
e

Physiological background pertaining to JAB counterpulsation

e

Discussion of the advantages and disadvantages of the current
counterpulsation technique

•

Discussion of late deflation theory as well as a comparison to conventional
timing

•

Data analysis: methodology, method, and results

6 Summary of data including results and discussion

CHAPTER 2
C • • NT COUNTERPULSATION TEC I IQUE & THE IABP

2.1 Introduction
In Chapter 1, statistical data was presented that indicated the mortality rate of individuals
affected with heart failure (Section 1.1). Evidence was provided that demonstrated the
decrease in mortality rate by application of the intra-aortic balloon pump. To fully
appreciate the extent at which this mechanical device aids the failing heart, fundamental
knowledge regarding the healthy heart, specifically, the left ventricle was introduced.
Because the principles of counterpulsation rely on prior knowledge of the
mechanics of the cardiac cycle, this information was also provided as part of the
background. The cardiac cycle includes the mechanics of the interaction of the left
ventricle with the aorta, yet only the aortic pressure waveform appears on the intra-aortic
balloon pump screen. Therefore, we must rely on this waveform alone to provide all the
necessary information to properly time the IAB in synchronization with the cardiac cycle.
Since the purpose of this thesis is to identify an optimal timing point for deflation
of the IAB, it is appropriate to gain a clear indication of the current method of
counterpulsation. Thus, it is the intent of this chapter to explain the advantages and
disadvantages of the current timing method as well provide a brief overview of the theory
of intra-aortic balloon pump therapy.
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2.2 Theory of IABP

The first proposal of a device that provides mechanical assistance to the failing heart was
first published in the May, 1962 issue of American Heart Journal. In this study,
Moulopoulos, Topaz, and Kolff inserted latex tubing tied around the end of a
polyethylene catheter into the descending aorta of an anesthetized dog. Through a
pressure system, the latex tube was rhythmically inflated with carbon dioxide. The
electrocardiogram of the dog served as a trigger so that the latex tubing was inflated
during diastole and remained deflated throughout systole. Results showed that "it was
possible to increase the diastolic blood flow in the arterial system and lower the enddiastolic arterial pressure" (674). The test also indicated that "intra-aortic pumping may
be of help by relieving the left ventricle of its work, and by increasing the blood flow and
possibly the coronary blood flow during diastole" (674).
Nearly four decades later the same theory of mechanical assistance to the left
ventricle is applied. Intra-Aortic Balloon Counterpulsation (IABC) is instituted by the
insertion of polyurethane balloon (mounted on a vascular catheter, which has multiple
pores) in the patient's descending thoracic aorta. The most common of insertions is
through the femoral artery. The femorally inserted IAB is then passed retrogradely up
the descending thoracic aorta to a position just distal to the left subclavian artery.
The JAB is attached to an intra-aortic balloon pump console and helium is
shuttled from the IABP to the balloon, escapes through the pores of the vascular catheter
and inflates the balloon. Timing of the inflation and deflation of the balloon is phasically
counterpulsed with the patient's cardiac cycle. Inflation occurs upon onset of diastole
while deflation occurs during isovolumetric contraction or early systole.

22

2.3 Principles of Counterpulsation: The Conventional Timing Method
2.3.1 Introduction
The word, counterpulsation, is a clinical term that describes balloon inflation in diastole
and deflation during isometric contraction or early systole. Inflation of the balloon
during diastole displaces the blood in the aorta both proximally (aortic root and coronary
arteries) and distally (systemic circulation). The volume displacement of blood enhances
coronary circulation as well as potentially increasing system perfusion and perfusion to
the aortic arch trifurcated vessels (Quaal 1993, 96). At the time of balloon deflation,
intra-aortic blood volume is decreased which lowers the end diastolic pressure in the
aorta (afterload). The decrease in pressure reduces the impedance against which the left
ventricle must overcome to eject and therefore, cardiac work is also reduced.

2.3.2 Conventional Timing and the Arterial Pressure Waveform
2.3.2.1 Proper Timing of Inflation and Deflation of the : : Proper timing of the
IAB results in effective interaction between the heart's electrical activity, hemodynamic
activity of the left ventricle, and the mechanical activity of the counterpulsation method
(Quaal 1993, 246). Kantrowicz stated "The hemodynamic efficacy of balloon pumping is
critically dependent on precise timing of both inflation and deflation in relation to the
events of the cardiac cycle." (1992, 819).
The IABP console requires a "trigger signal" from which it determines systole and
diastole. The most common trigger signal is the R-wave extracted from the patient's
ECG. ECG trigger signals is simply obtained from a set of electrodes and lead wires in
which the electrodes are placed on the patient's chest and lead to the pump console.
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Other methods of triggering include activation of the balloon from the patient's arterial
pressure waveform or an internal trigger mechanism available in some IABP's which
provide continuous counterpulsation at an established heart rate.
The arterial waveform is the reference from which clinicians adjust for proper
inflation and deflation. The clinician moves the inflation and deflation controls manually
until proper inflation and deflation morphological landmarks are achieved. As the
clinician manually adjusts the settings on the pump console, the console software relates
these inflation and deflation points to either R-R intervals from the ECG or intervals
between arterial pressure cycles ("trigger signals"). The pump then stores the time (in
milliseconds) between each R-R interval or between arterial pressure cycles and relates
these times to inflation based upon where the clinician positioned the inflation control
and deflation based upon where the clinician positioned the deflation control. For regular
R-R rhythm, the pump's logistics system can automatically initiate signal inflation and
deflation based on the clinician's adjustments. Irregular R-R intervals can be properly
tracked by using the "Real Timing" Method (see Quaal for further reading).
The IAB is timed to inflate at the beginning of diastole right after closure of the
aortic valve, thus elevating diastolic pressure termed "augmented diastolic pressure". On
the arterial waveform, inflation of the IAB should occur at the midpoint of the dicrotic
notch. However, proper timing needs to account for a delay in waveform propagation
that exists between the aortic root and peripheral vessels. The delay is a result of a
pressure pulsation developed during the systolic phase where ejection of the stroke
volume distends the arterial wall and thereby, producing the pulse wave.

24

To adjust for the dicrotic notch time delay, Quaal describes a common procedure
followed by clinicians and healthcare providers (see diagram below). The figure below
shows that the cumulative delay is approximately 50 milliseconds: approximately 25
milliseconds of delay exist for the time of aortic valve closure to be relayed to the
subclavian artery, and another 25 millisecond delay exists in transmission of an IAB
pressure pulse to the aortic root. If properly timed to inflate the IAB 40-50 milliseconds
earlier than the midpoint of the dicrotic notch, the morphology of the dicrotic notch
should change from the U-shape to the V-shape as is evident in Figure 6 below.

Figure 6: (Source: Quaal)

While the dicrotic notch is a critical landmark for proper inflation, aortic enddiastolic pressure is a critical landmark for proper deflation. Recall from the PV loop that
during isovolumetric contraction, aortic end-diastolic pressure is lowered due to the
displacement of stroke volume during inflation. Proper deflation should produce two
results evident in the aortic pressure waveform. The end-diastolic pressure following
balloon assist should be lower than the unassisted aortic end-diastolic pressure. The
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decrease in this pressure will reduce left ventricular work because afterload is decreased.
As a result, the "assisted systole (the systole that occurs after the balloon counterpulsed)
should be ideally lower than but at least not higher than the unassisted systole" (Quaal
1993, 253).

2.3.2.2 Improper Timing of Inflation and Deflation of the IAB: Although no particular
timing method has proven to be superior than the rest, there is a widespread acceptance of
when IAB counterpulsation can potentially harm the patient rather than provide the
necessary therapy it was meant to accomplish. It is significant that IAB inflation or
deflation does not compete with systolic ejection, which would increase left ventricular
work and therefore, oxygen requirements.
Currently, there is a widespread agreement that inflation of the balloon should
occur at the beginning of diastole just after aortic valve closure. Inflation earlier than this
point can increase the pressure in the aorta and prematurely close the aortic valve. Stroke
volume and cardiac output decrease because the left ventricle does not completely empty.
The volume that remains in the left ventricle also causes an increase in pressure or
preload which shift the characteristics of the pressure volume loop (see chapter 1).
Inflation that occurs far after aortic valve closure can reduce diastolic augmentation and
thus, decrease coronary and systemic perfusion. The following diagram illustrates the
concepts of both early inflation and late inflation in comparison to conventional timing as
witnessed in the aortic pressure waveform:
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Figure 7: (Source: Quaal)

Improper deflation of the IAB is defined as deflation that occurs too early or too
late in reference to systole. Early deflation is characterized by a higher assisted systolic
pressure than unassisted systole as evidenced in the aortic pressure waveform. This
increase in systolic pressure does not reduce the workload of systolic ejection and
therefore, the benefit associated with therapy is not obtained. Other potential
consequences include occurrence of retrograde flow that will flow from arterial vessels of
higher pressure to the aorta of lower pressure which can be detrimental leading to angina
(if flow initiates from coronary arteries) or to a transient ischemia attack (if flow initiates
from the cerebrals). Since isovolumetric contraction does not coincide with IAB
deflation, myocardial work and oxygen demands are not reduced.
Late deflation is described in terms of inflation timing. If the IAB is still inflated
in competition with systolic ejection, the left ventricle must work harder to eject against
the increase in aortic impedance and the rate at which systolic pressure rises is prolonged
(Figure 8). Consequences include an increase in myocardial work and oxygen
consumption as well as a decrease in cardiac output.
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Figure 8: (Source: Quaal)

2.4 Support for Conventional Timing

Over the years, articles and books have been written to support and validate the present
practice of conventional timing. Many investigators have chosen not only to examine the
benefits of IABP therapy by implementation of the standard timing method but also to
examine the risks versus benefits associated with variation of this method. Thus,
conclusions derived from such experiments either support conventional timing or propose
a timing method whereby indices are improved as a result.
Various groups, including Wolf et al, conducted experiments with the timing
method. Using a mock circulation system, they conducted a series of experiments to
determine the effects of balloon inflation and deflation timing on systolic left ventricular
pressure and cardiac output. Results showed that if balloon deflation occurred after
systole, no reduction of left ventricular pressure was obtained. As deflation duration is
increased with late deflation, a marked increase in left ventricular pressure and cardiac
output occur. It was concluded that even with balloon sizes smaller than 19.5
millimeters, the "most desirable timing occurs when balloon deflation begins at the start
of systole" (Wolf 1972, 45).
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Literature has also been generated that point out the difficulty in optimization of
timing, and thus, is the reason why conventional timing has been the method of choice
for clinicians. A performance index should first be formulated based on objective criteria
using clinically measurable hemodynamic variables. Choosing a performance index has
been a controversial issue in the clinical field since there are numerous variables to
consider. It is widely believed that properly timed deflation reduces systolic pressure
(conventional timing). Barnea et al point "this effect increases stroke volume and
decreases left ventricular energy requirement. However, published data reflect
inconsistent results for both augmentation of coronary perfusion and ventricular
unloading" (171). They also demonstrated that "as deflation was started in systole,
coronary perfusion was enhanced but at the expense of increased workload". Thus, the
timing of deflation that reduces workload was found to be different from the timing,
which maximally reduces coronary perfusion. Therefore, a measure of IABP
performance relies on the hemodynamic variables chosen which can either fully support
the standard timing method or provide enough reason for investigators to develop an
optimal method.

2.5 Summary
Conventional timing is a "safe" method that reduces myocardial work and oxygen
requirements. The range set for inflation and deflation of the balloon is such that it does
not compete with left ventricular ejection. Inflation of the balloon during systolic
ejection can potentially harm the patient and provide more risks to the patient in
comparison to his/her unassisted state. While support exists for utilization of
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conventional timing to aid the patient suffering from heart failure, it is well understood
that this method has not been optimized. "No single timing setting can be expected to
provide optimal hemodynamics for various modalities of heart failure, such as
biochemical structural, and viral" (Quaal 1993, 259). However, as discussed in
subsection 2.3.2.2, there are risks involved with the conventional timing method. Human
error is a factor that can contribute to a great degree in improper timing of the IAB.
These errors can be traumatic to the patient and can even lead to death in the worst case
scenario. In evaluating the proper timing method, it is essential to determine the risks
versus benefits to the patient.
It is difficult to identify hemodynamic indices related to IAB effectiveness (Sun
1991, 1309) since certain parameters can improve with variation in IAB characteristics
while others will worsen. Therefore, contradictions exist as to what constitutes the
optimal deflation time. As will be discussed in subsequent chapters, there are benefits as
well as risks associated with deflation of the balloon at a later time period in comparison
to conventional timing depending on which hemodynamic indices are examined.

C • ' TER 3
LATE DEFLATION TIMING STUDY:
HEMODYNAMIC EFFECTS OF • : TIMING IN HUMANS
(Late Deflation Theory and Methodology)

3.1

Introduction

The intra-aortic balloon pump is the most commonly used circulatory assist device for the
failing heart. Benefits include arterial diastolic augmentation and reduction of afterload
resistance with decreased systolic pressure (Bolooki 1998, 4; Kern 1999, 1129; Quaal
1993, 101). This counterpulsation device has saved thousands of lives since its creation
and continues to provide therapy to those that need it (see chapter 2).
The hemodynamics of the intra-aortic balloon have been documented and
demonstrate that a significant increase in diastolic augmentation as well as a decrease in
afterload and systolic pressure results in patients with IABP support in comparison to
patients without assist. Currently, these benefits are gained by the utilization of the
conventional timing method in which complete balloon deflation is completed prior to
ejection of the left ventricle (Bolooki 1998, 4).
Although the theory of conventional timing is widely practiced and accepted in
the clinical field, it is not considered an optimal timing method (Barnea 1990, 175). This
classical method has remained unchanged for the past 25 years (Datascope ProtocolLucas 1994, 2). Several disadvantages are cited and thus, leave room for improvement.
In Chapter 2, it was explained that conventional timing is a "safe" method. While its
benefits are well documented in literature, several issues are still being investigated. The
first issue deals with incorrect timing (e.g. early or late inflation/deflation) discussed in
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Chapter 2. The second issue deals with optimization of hemodynamic indices associated
with IABP therapy such as oxygen supply to the myocardial tissue (i.e. diastolic
augmentation) and reduction of afterload and therefore, systolic pressure.
The proper timing of deflation is still an issue. It is well understood that it should
occur so as not to compete with ventricular ejection. Yet, the possibilities for deflation of
the balloon encompass a broader range than that available for correct inflation. Thus, it
has been the intent of investigators to define what that particular optimal deflation time
is. Currently, contradictions still exist in the data obtained from these experiments since
benefits as well as risks are associated with deflating the balloon at a later period.
Because no one can agree on which performance index provides the best clinical
indication of hemodynamic efficacy of IABP support, the results of this study will be
presented using several hemodynamic variables that encompass the wide range of
variables cited in the literature.

3.2 Late Deflation Study: Theory

"Although the effects of the IABP on systemic and coronary hemodynamics have been
extensively described (7-12), little information exists in patients regarding optimal
myocardial efficiency with IABP timing techniques" (Kern 1999, 1129). As explained
in Chapter 2, conventional IAB timing has previously been set to ensure 100 percent of
balloon deflation prior to left ventricular ejection. Yet, recent experimental studies have
demonstrated that myocardial efficiency may be optimal when balloon deflation
coincides with the pre-systolic ejection period (isovolumetric contraction) and is
completed at some point during left ventricular ejection (Kern 1999, 1129-1130). These
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studies, referenced in the article by Kern et al, have demonstrated that a later IAB
deflation resulted in improved diastolic augmentation and further reduction in afterload.
Benefits for later deflation are not only supported by experimentation with
animals and mock circulatory systems but are mathematically modeled as well.
Mathematical modeling of the dynamic interaction between the left ventricle and the
intra-aortic balloon pump predicted that progressive postponing of the deflation point
does not significantly impact left ventricular work and stroke volume until approximately
50 milliseconds after the R-wave (Sun 1991, H1310). Yet, maximum stroke volume was
found to occur when the deflation transition matched the opening of the aortic valve
because it was hypothesized that the deflating balloon sucks additional blood from the
left ventricle (H1310).
As discussed in this section, the theory of deflating the balloon at a later time
period than standard deflation is valid because it demonstrates an increase in
hemodynamic efficacy. Yet, the theory is still vague since no one has been able to state
what that optimal timing point is. This study will attempt to define that optimal timing
point as well as provide information on hemodynamic efficacy of intra-aortic balloon
pumping using different timing methods as compared to the unassisted state (i.e. IABP
turned off).

3.3 Objective
The purpose of this study is to identify an optimal deflation of the IAB at which IABP
efficacy is modified and thus, improved as compared to conventional timing. The
hypothesis tested was that deflation of the IAB approaching or simultaneous with left

33

ventricular ejection would improve myocardial efficiency and systemic hemodynamics.
It is the goal of this study that identification of hemodynamic efficiency of IABP
deflation could lead to implementation of a new IABP timing technique that can further
aid the sick patient.
This analysis has been triggered by a previous study conducted by Datascope
Corporation and Kern et al. The purpose of the study was to determine the potential
benefits of deflating the IAB closer to ventricular ejection than is currently being done
with conventional timing. The study examined four timing methods described in the
following chapter. Results showed that a delay in IABP deflation approaching left
ventricular ejection appears to provide "optimal reduction of afterload without producing
adverse effects on cardiac output, stroke volume, or indices of oxygen consumption" as
evidenced by the differences between conventional timing and late deflation (1999,
1135). Yet, identification of the "optimal" deflation timing point was not established and
the findings do not conclusively demonstrate that deflation at or after the R-wave is
completely appropriate in each patient. Inconclusiveness of Kern's study may be due, in
part, to a faulty analysis technique, which resulted in intra- and inter-patient
inconsistency and variability (Paul Nigroni & John Lucas, Datascope Corp.). Therefore,
a new analysis method that excludes this variability is provided in this thesis.
The results obtained by Kern et al will be identified for comparison with results
obtained in this study. The following will be considered as constants that will remain the
same for both the focus of this thesis and was used for the study conducted by Kern et al:
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O

Patient files containing the aortic pressure waveforms as well as the EKG
(electrocardiogram). Therefore, patient selection/criteria and data acquisition
described in Appendix A pertains to both this study as well as Kern et al's.

•

Four timing methods, T1-T4 (section 3.4)

a

Hemodynamic indices utilized to determine effectiveness of IAB performance at a
particular timing method (Chapter 4).

Differences between the two studies, Kern et al's versus my study, exist in the method
utilized to analyze the data and is summarized as follows:
a

Correction of data for change in mean pressures including mean systolic pressure,
mean diastolic pressure, and mean aortic pressure (pressure was found in this
study to change with change in heart rate which will be discussed in Chapter 4)

•

Selection of a consistent starting point for systole, which ultimately had a
significant impact on reduction of variability (see Chapter 4)

▪

Correction of data for improper timing, specifically, early or late
inflation/deflation (the four predetermined timing points did not occur exactly as
theoretically described in the protocol and will be further discussed in Chapter 4)

3.4

Four Timing Methods for • : Deflation

The four timing methods below were utilized for the purpose of this thesis as well as for
the study conducted by Kern et al. The methodology for choosing each setting is
discussed below but the exact time (in milliseconds) in relation to left ventricular ejection
is not mentioned since it varies with each patient depending on the length of the cardiac
cycle.
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The time setting, T 1 , is defined as the conventional or standard timing setting
whereby the entire 40cc volume of the IAB is deflated prior to left ventricular ejection.
The end of deflation of the IAB coincides with the onset of left ventricular ejection and
thus, provides maximum pre-systolic decline in pressure. A potential consequence of
using this experimental point is retrograde coronary blood flow.
The time setting, T2, is defined as an intermediate time setting between Ti and T3
whereby 60% of the 40cc volume (24cc) of the IAB is deflated prior to the onset of left
ventricular ejection. Therefore, 40% of the volume (16cc) will still be inflated at the
onset of ejection and it is hypothesized that this will cause a decline in the pre-systolic
pressure but not to as great a degree as T1. Just like the T1 setting, a possibility exists that
retrograde flow will occur.
The T3 time setting is defined as 25% of the IAB volume (10cc) deflated prior to
the onset of left ventricular ejection. Thus, 75% of the volume (30cc) will be deflated
during left ventricular ejection and will provide "the best degree of pre-systolic unloading
(i.e. pressure decline) realizable in the absence of significant retrograde flow" (Lucas,
1994). Cited in Datascope's test protocol is the rationale for choosing this time period:
"T3 is based upon data in the literature which indicates that 10cc is about the maximum
volume which can be deflated in pre-systole without incurring retrograde blood flow into
the central aortic reservoir from the coronary circulation, and perhaps from cerebral
vessels and other vascular beds" (Lucas, 1994).
T4 is the time setting whereby the onset of IAB deflation occurs simultaneously

with left ventricular ejection. Thus, it is set so that 40cc volume of the IAB is inflated at
the onset of left ventricular ejection and starts to deflate at that moment, providing the
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best in-phase match of IAB deflation to left ventricular ejection. It was hypothesized that
no pre-systolic decline in pressure will occur with this time setting since inflation of the
IAB might pose as a large resistance or impedance to LV ejection. In this chapter, the
potential risks associated with late deflation were described and it was possible that with
this time setting, these risks could have become an issue at the patient's bedside. As with
implementation of all time settings, the patient was continually monitored and was
removed from the study if a negative effect to IABP therapy was recognized.

3.5 Summary
It is critical when looking at all sections in subsequent chapters that there exists a clear
understanding of the purpose of this study. Datascope Corporation has instituted a study
to determine an optimal timing point for deflation of the IAB as well as to determine the
hemodynamic effects of IAB timing in man. Thus, it is the goal of my study to present
this information using an analysis technique different from the one that was utilized in the
past (e.g. Kern et al's study). The data collected prior to this study and utilized by Kern
et al will remain the same data that is analyzed in this thesis. The similarities and
differences between this study and Kern et al's investigation will be cited as deemed
necessary in the body of text that follows, specifically in Appendix A.
The objective of Chapter 4 is to present the test methodology including extraction
of information from aortic pressure waveforms and the ECG as well as selection of
patients' files utilized in this study. The graphs generated for each file represent the
correction factors that take into account the dynamic state of the heart and are contained
in Appendix B. Chapter 5 will include the results, discussion, and conclusion. Results
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are presented in Appendix C in graphical form for all files analyzed which will serve as a
visual tool for ease of comparison.

C • ''TER 4
LATE DEFLATION TIMING STUDY: HEMODYN • C EFFECTS OF IAB
TIMING IN HUMANS (PARAMETERS INVOLVED IN DATA EXT • CTION)
4.1

Introduction

The purpose of this chapter is to provide the reader with information regarding the steps
taken to analyze the data. Equipment necessary for data analysis will be described as
well as the number of files analyzed following elimination of data containing artifact.
Corrections for deflation time, heart rate, and pressure are also included in this chapter.

4.2

Data Reduction: Elimination of Files
with Substantial Artifact (Catheter Whip)

Although the total number of patients accepted according to the inclusion/exclusion
criteria were 43, it was evident from evaluation of patients' files that not all files can be
analyzed, specifically, due to pressure or motion artifact (i.e. catheter whip). Based on the
limitations of the data playback software utilized (CODAS), extraction of artifact from
the waveform was not possible. Therefore, analysis of data that contained artifact would
not have provided meaningful clinical results. Evaluation of these files resulted in a
reduction of patients' files to a total of 35.
The data presented in this thesis represent a total of twenty patients' files out of
those 35 files mentioned above. The number twenty was chosen because analysis of each
file encompasses a great deal of time that was not available given the time span of this
study. The twenty files were chosen randomly from the list of 35 files shown in Table 1
which are indicated with a check mark

(✓)

next to the file name:

Table 1 Twenty Patients' Files Randomly Chosen for this Study
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Each patient file contained a total number of ninety cardiac cycles that were
evaluated (18 cardiac cycles for each of the timing settings and standby multiplied by 5
(4 time settings + standby)). The number eighteen represents the number of cardiac
cycles previously evaluated by Datascope Corporation, specifically Lynn Antonelli and
John Lucas, and were incorporated in Kern et al's study. Previously analyzed cycles are
found in CODAS by looking for the cycles with inserted marks.

4.3 Software Utilized for Data Analysis
The same P.C. software package utilized for data acquisition was utilized for data
analysis. This software, Windaq Playback Software (also called CODAS), contained the
same channels present in the data acquisition files described in Appendix A. This
software was specifically utilized to obtain the following raw hemodyamic data:
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•

R-R Interval (RR) = total cardiac cycle = time between IABP R-wave trigger
signals

•

Diastolic Time Index (DTI) = time from dicrotic notch or IAB inflation to the
next systolic aortic pressure upstroke

•

Left Ventricular Ejection Time (LVET) = time from systolic aortic pressure
upstroke to dicrotic notch or IAB inflation point.

•

Mean Aortic Pressure (MAP) = total mean aortic pressure during one complete RR interval

•

Mean Systolic Aortic Pressure (MSAP) = mean systolic pressure during LVET
time interval

•

Mean Diastolic Aortic Pressure (MDAP) = mean diastolic pressure during DTI

The parameters listed above were later entered into Excel spreadsheets for further
analysis. Graphs and correlation factors were generated which are explained in Chapter 5
and included in Appendices B and C of this thesis.

4.4 Waveform Analysis Technique: Normalization of Data
The method of extracting raw hemodynamic data from the CODAS files is outlined
below. This method normalizes the data so that a relevant statistical comparison can be
established. Hemodynamic data was then entered into Excel spreadsheets for further
analysis and is attached in Appendix B of this manuscript. The data points extracted
included: RR, LVET, DTI, MSAP, MDAP, and MAP.
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4.4.1 Methodology

The data represented four timing methods as well as standby data (intra-aortic balloon
pump was turned off). According to the figure below (Figure 9), as the deflation point is
increasingly delayed, the systolic aortic pressure of the subsequent cycle is artificially
shortened. For example, the deflation point, T4, intersected the systolic aortic pressure
waveform at a later time period than T1. Therefore, the total area under the systolic aortic
pressure curve artificially decreases as the deflation timing point occurs later into systole
(i.e. the area to the left of the intersection of the timing points is eliminated).

Figure 9: (Source: Lucas)

The area under the aortic pressure curve that was eliminated could not be
measured for the following reason. The deflation timing points did not occur exactly as
described in Chapter 3 relative to systole. Because the data did not include the left
ventricular pressure, we do not know when ventricular ejection really occurred. Knowing
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the time period of ventricular ejection is critical because the deflation timing points, T1T4 are timed to occur relative to systole. Thus, we do not have a clear indication of how

much of the aortic pressure curve was eliminated with each time setting.
To account for these timing errors, the data was normalized so that a comparison
can be made between the four deflation timing points and at standby. Normalization of
the data was established by obtaining the hardcopy of each of the patients' files and then
measuring the largest distance between the R-wave and systole. From CODAS, this
distance was then translated into a time period, RS max , which was used as a starting point
for that particular file. That way, systole was assumed to start at a particular location for
the patient's cardiac cycle for all deflation time settings as well as at standby. Analysis
consisted of a comparison of these normalized values to standby data and is contained in
Appendices B and C.

4.4.2 Method
The procedure that follows lists the necessary steps required to obtain the raw
hemodynamic data. In CODAS, Channel 1 (ECG) and Channel 2 (aortic pressure
waveform) were utilized for extraction of this information.
1.

For each patient, obtain the hard copy files.

2.

On the bottom of each sheet is the timing method represented by the
waveforms on that page. Analysis should consist of "standby" data as
well as the four timing methods, T1-T4.
Using a ruler or straight edge, draw a vertical line at the R-wave of
the ECG reading (Channel 1 in CODAS-See Appendix A).
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9

Draw another line at systole, where systole is defined by the
upstroke of the aortic pressure waveform (Channel 2 in CODASSee Appendix A).

•

Use a vernier caliper to measure the first three cycles on that page.
Particularly, measure the distance between the R-wave of the ECG
and systole as indicated by the two vertical lines drawn from the
above steps.

•

Once the above procedure is completed for the time settings
labeled standby and T1 through

T4,

compare the distances

measured by the vernier caliper and note the largest distance along
with the time setting associated with it. This distance, RS., is
defined as the maximum distance between the R-wave and systole.
3. Go to that particular patient's file on the computer (using CODAS
software) and look for the time setting that corresponds to the
RS max noted. It is important to understand that the maximum
distance measured, in inches, is only relevant to locate the
particular time setting on the computer where the longest cardiac
cycle occurs. Once the cardiac cycle is found using the steps
below, that distance was converted into a time period, in seconds,
defined as Rs..
•

Move the cursor to the ECG of Channel 1, specifically, the Rwave, and press the F4 button to zero out the time at that point.
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•

Using the time, in seconds, found in the last step of instruction #2
above, move the cursor from time=0 seconds to time found in that
step (defined as RS.).
Again zero the out the time at that point by pressing the F4 key and
insert an event mark (press the insert key on your keyboard). This
is the starting point, systole, at which deflation of the IAB is
assumed to occur.

•

Move the cursor from systole to the dicrotic notch. It is critical that
the location of the cursor be defined as the least pressure in
millimeters of mercury (mmHg) at the dicrotic notch. Insert an
event mark, which will make it easier to find this point at a later
time period (press the insert key on your keyboard). This time
period, from systole to the dicrotic notch (LVET) should be noted
for further analysis. Also, the area under the curve from systole to
the dicrotic notch, defined as the mean systolic aortic pressure
(MSAP), is obtained by pressing the <control> key and the letter T
(or from the toolbar, go to the statistics function in the Edit menu).
Also, note this value for further analysis.

•

From the dicrotic notch, move the cursor to the next R-wave. Zero
that point and move the cursor to the specific time period noted in
the last step of instruction # 2 defined as

6

From systole, at time=0 seconds, move the cursor back to the event
mark located at the dicrotic notch. Record this time period as DTI.
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Go to "Statistics" and record the mean diastolic aortic pressure
(MDAP).
Move the cursor from its current location to the left at systole (i.e.
location of inserted event mark). Record this time period as R-R
interval. Again, go to "Statistics" and record the mean aortic
pressure (MAP).

4.5 Correction for can Aortic Pressure and Heart Rate
Following completion of data extraction, the correlation between heart rate and pressure
at standby was deduced and incorporated as a correction factor for all time settings as
well as standby data. The method included in this section was applied to all files and
represents the dynamic state of the heart. The heart's properties vary with time and are
not held at a constant static rate. Bolooki stated this critical point: "variations in factors
such as impedance, diastolic properties of the ventricle, and heart rate may significantly
influence the interpretations of data" (1998, 30). If this data is to be considered a true
representation of IABP efficacy, then this dynamic state must not only be quantified but
must also be incorporated into the analysis via substitution of the data into the linear
equations extracted from Excel graphs.

4.5.1 Methodology
In the clinical field, it is well understood that there exists an inverse relationship between
heart rate and pressure. This relationship is explained in the textbook written by Susan
Quaal and is summarized as follows: "Intraaortic balloon inflation elevates diastolic
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pressure, which stretches the baroreceptors. Heart rate is therefore lowered and systemic
vascular resistance decreases with IAB inflation due to the baroreceptor response" (1993,
110). Basically, balloon inflation in diastole displaces stroke volume directly toward
aortic baroreceptors. These baroreceptors then send a message to inhibit peripheral
vasoconstrictor activity, thereby, decreasing peripheral resistance and improving blood
flow.
As heart late increases, the duration of balloon inflation decreases. Thus, it is
critical to incorporate the change in systolic and diastolic time intervals as well as the
change in mean aortic pressure associated with increased heart rate.

4.5.2 Method and Results
To demonstrate and quantify these relationships, graphs were generated which represent
hemodynamic indices while the IABP is in the "standby" state. The "standby" state is
recorded following implementation of each time setting when the IABP was turned off
for a specific time interval. Thus, two graphs were generated as follows: 1) Mean aortic
pressure (mmHg) versus Systolic & Diastolic Aortic Pressure (mmHg) and 2) Heart Rate
(BPM) versus Systolic & Diastolic Interval (cosec).
Theoretically, mean aortic pressure is the time-average of systolic aortic pressure
and diastolic aortic pressure. Therefore, if the total pressure increases with time, it is
expected that this increase is a result of an increase in a portion of the mean pressure,
either systolic, diastolic, or both. This was indeed the case as evident in the first graph
titled "Effect of Mean AoP on Systolic & Diastolic AoP" included in Appendix B. The
equations that represent this relationship are incorporated as a correction factor by
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substitution of systolic or diastolic aortic pressure into the x-value of the equations on
that graph. Thus, the standby data was adjusted to correspond to the mean pressure and
heart rate of each of the four time settings.
As previously indicated in the above subsection, an increase in heart rate
decreases the systolic and diastolic time intervals. The graph labeled "Effect of Heart
Rate on Systolic & Diastolic Intervals" demonstrates this inverse relationship and is also
included in Appendix B. The quantitative relationship of heart rate and time intervals are
also incorporated as a correction factor by substitution of systolic or diastolic time
intervals into the x-value of the equations on that graph.

4.6 Summary
Data analysis consisted of three main parts: elimination of files containing noise artifact,
standardization of the start of systole (RS max) for consistency, and correction for
variations in mean aortic pressure and heart rate which take into account the dynamic
state of the heart. The goal of applying these methods is to be able to interpret the data in
a way that can provide an accurate representation of the hemodynamic state of the heart
following IABP therapy using the four timing methods. Barnea et al stated that we must
account for such changes in mean aortic pressure and heart rate because the "state of the
cardiovascular system may be constantly changing during balloon assistance" as
witnessed in the graphs included in Appendix B (1990, 171). Doing so will help answer
the following questions:
® Compared to the conventional timing method (T1), does deflating the JAB at
predetermined volumes relative to systole improve efficacy in man?
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0 What is the optimal point to deflate the JAB relative to systole?
These methods led to data extraction and generation of graphs for all 20 patients,
which were compared not only to each other but also to standby data. Thus, results were
summarized in one chart representing relevant hemodynamic variables used in the
clinical field to indicate IABP efficacy. The following chapter summarizes the results
obtained using these methods as well as provides the answers to the two questions above.

CHAPTER 5
LATE DEFLATION TIMING STUDY: HEMODYNAMIC EFFECTS OF JAB
TIMING IN MANS (DATA ANALYSIS: RESULTS & CONCLUSION)

5.1

Introduction

It is imperative to keep in mind that several variables influence the magnitude and
duration of diastolic pressure augmentation with balloon inflation. Cited in the textbook
by Quaal is a framework of biological and physical variables published by Weber and
Janicki nearly 20 years ago (1993, 114). Physical variables include balloon position
within the aorta, volume of shuttle gas entering the balloon, balloon shape and diameter,
occlusion of the balloon within the aorta, type of shuttle gas utilized, and timing of
inflation. Biological variables include arterial pressure, heart rate, and aortic pressurevolume relation.
Studies have been conducted to maximize efficacy related to each of these variables
and while literature exists to propose such methods, the optimization of timing of the IAB
is still a controversial issue. It is significant to realize that while the goal of this thesis is
to define an optimal timing point to deflate the IAB, the variables above need to be
considered as important factors that may influence results of further testing into this
matter.
It is the attempt of this chapter to summarize the results of all files analyzed. Prior to
providing the final results, each variable will be explained. For clarity and ease of
understanding, one patient file will be chosen and used as an example throughout the
course of this chapter.
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5.2 Correction for Deflation Timing Errors
Although the protocol devised by Datascope Corporation outlined the method for
deflation of the lAB at different points relative to systole, it was possible that a
discrepancy existed between the measured values and the theoretical values sought after
due to technical error. To test this hypothesis and to also determine the timing point at
which deflation actually occurred relative to systole, graphs were generated for each
patient, which plotted the % of deflation time versus pressure efficacy (either DPTI/SPTI
or SPTI). These graphs are included as part of Appendix C.
Evaluation of these graphs led to the optimal timing point for late deflation of the
IAB. In most patients, pressure efficacy seemed to occur with late deflation between T2
and T3, particularly, 50% of the volume was evacuated prior to the initiation of systole.
Therefore, deflation of the balloon at 50% of the volume prior to systole was chosen as
the timing method that will be compared against conventional timing, T1. The results are
outlined in the following section and are included as part of Appendix C.

5.3 Discussion
5.3.1 Variables Utilized in the Clinical Field as Indications of ' P Efficacy

In Chapter 3, difficulties associated with determining the effectiveness of the intra-aortic
balloon pump in providing mechanical assistance to the failing heart was discussed.
Because no one can agree on which performance index provides the best clinical
indication of hemodynamic efficacy of IABP support, the results of this study are
presented using several hemodynamic variables that encompass the wide range of
variables cited in the literature. Each variable is explained below serving as an
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introduction to the next subsection, which is a discussion of the results. The term
"corrected" refers to the implementation of all the correction factors mentioned in
Chapter 4.
•

SPTI or TTI (corrected) = This variable, systolic pressure-time index, is directly
related to myocardial oxygen demands. SPTI is expected to decrease with IABP due
to a decrease in systolic blood pressure.

•

DPTI (corrected) = DPTI, diastolic pressure-time index, describes pressure-time
events during diastole and can be used to estimate diastolic subendocardial blood
flow (Bolooki, 1998, 103; Quaal, 1993, 101). It is directly related to myocardial
oxygen supply and is expected to increase with intra-aortic balloon counterpulsation
due to an increase in diastolic blood pressure.

•

DPTI/SPTI (corrected) = This ratio, also known as an endocardial viability ratio, is a
useful indicator of oxygen supply and demand. An endocardial viability ratio (EVR)
of 1.0 signifies a normal supply/demand balance. In order for this ratio to be utilized
as a determinant of increased blood flow with balloon support, a period of "EVR
without balloon support may assist in determining prognosis" (cited in Quaal, 103).
Therefore, this variable will be compared with standby data.

® [SPTI] + CO = The benefits of IABP include 1) decreasing the amount of work
.

required by the left ventricle to eject blood resulting in 2) an increase in cardiac
output. Each patient is different and therefore, the benefits associated with IABC
vary. Because there is no way to control the percentage associated with each of these
variables, the addition of the two will provide a clearer indication of IABC efficacy.
•

Mean HR = Heart rate reflects the status of cardiac performance.
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® Mean AoP = The clinician often wants to increase the mean aortic pressure to
increase systemic perfusion.
•

SVR = Systemic Vascular Resistance offers information regarding resistance to
ventricular ejection. As systemic vascular resistance decreases, cardiac output is
expected to increase.

® CO = Cardiac output decreases due to left ventricular failure and is expected to
increase with IABP support. Freedman states that the increase associated with IABC
is minimal ranging between 0.5 and 1.0 liters per minute and is a reminder that "the
balloon pump best functions as an assisting circulatory support device" (Quaal, 1993,
101).

5.3.2 Results
In Section 5.2, it was noted that technical error could have occurred during the timing of
the IAB. This hypothesis was tested by graphing deflation time relative to systole versus
pressure efficacy. Results showed that 2 of the 20 patients' files contained mistimed
inflation points. That is, inflation of the IAB at a later time period caused outliers in the
data and thus, were eliminated from the final analysis. Patient files B3 and B6
demonstrated a late inflation time of approximately 120 milliseconds. These files also
did not contain information on cardiac output that was not available during the previous
analysis (e.g. Kern et al's). Therefore, the data could not be accurately compared to data
obtained in this study.
The results of the 18 files are summarized in a graph attached in Appendix C
providing a comparison of hemodynamic indices between conventional timing (e.g. 0%
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deflation) and late deflation (e.g. 50% of the volume of the IAB remaining at the start of
systole). Improvement was noted for SPTI, DPTI, DPTI/SPTI,' and [SPTI] + CO using
the late deflation timing method as compared to conventional timing. No difference was
noted in mean heart rate for late deflation but with conventional timing, mean heart rate
decreased by 1%, which is considered an insignificant reduction in heart rate. Systemic
vascular resistance decreased by 10% using conventional timing as compared to the 4.2%
decrease witnessed with late deflation and mean aortic pressure increased by 3.4% with
late deflation.

5.4 Conclusion
The results of this analysis indicate that a significant improvement in hemodynamic
indices is established by deflation of the IAB at a later time period than conventional
timing. If 50% of the volume of the IAB is present at the start of systole, IABP therapy
can be optimized. This agrees with Sakamote's analysis which states: "IAB deflation
during isovolumic contraction reduces LV end-systolic pressure and significantly
optimizes VA coupling and LV efficiency during IABP support, compared with
conventional timing" (1995, M580). It also agrees with Quaal's analysis that presystolic
deflation lowers impedance to systolic ejection (1993, 96).
The analysis method utilized in this thesis indicated that cardiac workload was
reduced with late deflation. As evident in the graph in Appendix C, the index that best
represents cardiac workload, SPTI, was reduced at 50% deflation as compared to
conventional timing. Yet, cardiac workload is represented by different variables
depending on the preference of the investigators. Therefore, if SPTI is considered as a
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valid representation, then late deflation shows a positive effect but if mean aortic pressure
is considered, late deflation demonstrates a negative effect. The paragraph that follows
demonstrates the use of mean aortic pressure as the cardiac workload index.
Late deflation does have a negative effect on systolic and diastolic pressures
combined (mean aortic pressure) and thus, increases the afterload. Barnea et al
accounted for this observation during their study. In an attempt to determine IABP
efficacy by deviating from conventional timing, they concluded that there exists a
"tradeoff between timing for minimal workload on the heart and timing to maximize
quantities related to coronary supply. As deflation was started later in diastole, coronary
perfusion was enhanced but at the expense of increased cardiac workload" (1970, 171).
Despite the increase in workload, they concluded that optimal deflation time occurred
when balloon volume was "decreased to approximately half of its fully inflated volume
prior to end-diastole and deflation continued into next systole" (174).
It should be noted that this research is based on a limited number of patients and
further study involving a larger population is recommended.

APPENDIX A
SELECTION CRITERIA FOR PATIENTS UNDERGOING LATE DEFLATION
STUDY

In this appendix, the test protocol utilized to obtain the data relevant to both this study
and Kern et al's study is presented. This information was extracted from a test protocol
written by employees of Datascope Corporation, Fairfield, NJ.

A.1

Investigational Sites and Prinicipal Investigators

The IAB Timing Study that has been utilized by Kern et al (Prinicipal Investigators)
and in this late deflation study was conducted at four clinical centers. The study was
sponsored by Datascope Corporation and conducted under an Investigational Device
Exemption.
1.

St. Louis University, St. Louis, Mo., Prinicipal Investigator: Dr. Mi. Kern

2.

Methodist Hospital, San Antonia, Tx., Prinicipal Investigator: Dr. R. Schnitzler

3.

Alleghany Hospital, Pittsburgh, PA., Prinicipal Investigator: Dr. D. Lasorda

4.

Duke University Medical Center, Durham, NC., Principal Investigator: Dr. E.M.
Oilman

A.2

Patient Selection

Patients selected in Kern et al's study were based on the criteria listed in the preceding
sections. The following sections, therefore, not only apply to the study conducted by that
group but also pertain to this study since the data collected was reanalyzed for the
purpose of this thesis. Because analysis of data encompasses a great deal of time that
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was not available for the scope of this study, reduction of the amount of patient files
analyzed was necessary.

A.2.1 Patient Recruitment and Inclusion/Exclusion Criteria
A maximum of 43 patients undergoing IABP therapy was recruited from the four
clinical centers listed above. Investigators and a physician were at the bedside to assure
those patients' hemodynamics did not become unstable during the period of this study.
For the purposes of this study, hemodynamic instability is defined as either a change in
heart rate of greater than or equal to 10 beats per minute (BPM) or a change in mean
aortic blood pressure of greater than or equal to 10 millimeters of mercury (mmHg).
Those patients that demonstrated hemodynamic instability throughout the course of the
study were removed from further participation and treated accordingly.
One hour prior to the start of the protocol, the following requirements were
established:
1. no change in the intravenous infusion rate of isotropic drugs (drugs utilized to
increase cardiac contractility that can affect heart rate and ventricular stroke volume)
2. no change in vasodilator drugs (drugs utilized to reduce systemic vascular resistance
that can affect end diastolic volume, blood pressure, and heart rate)
3. no change in the requirement for volume loading

A.2.2 Patient Profile
According to the patient information collected by Kern et al (reference Kern's article),
diagnosis of patients requiring mechanical assistance (IABP support) include acute
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myocardial infarction, coronary artery disease, and unstable angina. Their mean age is
59+11 years with a mean height of 68+5 inches and mean weight of 182+35 pounds.

A.2.3 Informed Consents and Patient Confidentiality
The purpose of the IABP Timing Study as well as potential risks associated with it was
explained to each participant. Participation was on a voluntary basis and therefore,
informed consent was obtained from each patient before enrollment into this study. In
order for participants to undergo testing in this study, participants must meet all of the
following criteria (i.e. clinician must check off "Yes" for all questions on the Informed
Consent Sheet):
1. The patient must possess the ability to provide informed consent. This means that the
patient must be aware and understand the extent of the study as well as agree to
volunteer despite possible risks.
2. All patients enrolled in this study will have passed clinical criteria of needing
mechanical assistance. The IAB utilized for each patient must be Datascope Percor
Stat-DL 9.5 Fr. 40cc to eliminate variation in test results due to the difference in
variables associated with the IAB (e.g. volume, diameter).
3. The patients' ages ranged from 18 years of age to 85 years of age.
4. The intra-aortic balloon pump was programmed to provide assistance to the patient on
a 1:1 frequency (heart beat frequency: device beat frequency).
5. During each heartbeat, systolic time interval accounts for approximately one-third of
the cardiac cycle while the remainder is ventricular relaxation (diastolic time interval)
(Bolooki, 1998, 28). During IABP support, this allows for sufficient time for the
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balloon to fill during diastole and rapid deflation during systole. "With an increase in
heart rate or atrial pacing (>120/minute), the diastolic filling time decreases to an
extent that preload (PCWP) becomes pressure dependent to achieve rapid (and
sufficient) ventricular filling to maintain stroke volume" (Bolooki, 1998, 28). Thus,
to achieve adequate balloon inflation, it is required that the heart rate of each patient
is less than 120 beats per minute.
6. Mean blood pressure for each participant must be greater than 60 mmHg (i.e. patient
must not be hypotensive). Patients in this category have severe LV failure, which
may occur simultaneously with the onset of AMI. If proper treatment is not provided,
the survival rate may be as low as 10% (Bolooki, 34). IABP support is required to
reduce mechanical afterload in addition to intravenous treatment.
7. Cardiac index must be greater than 2.0 liters/min/m² . Patients with a lower cardiac
index may develop acute pulmonary edema, or may fall into the group of hospital
survival approaching 50%. They may not respond to large dosages of medication or
infusion and, as a result, experience a steep rise in ventricular end-diastolic pressure.
8. Limb ischemia is the most frequent early complication of IABP assistance and can be
attributed to balloon catheter/femoral artery mismatch, method of insertion,
preexisting peripheral vascular disease, claudication, female gender, diabetes,
hypertension, urgency of balloon catheter insertion, and duration of IABP assist
(Bolooki, references indicated on page 220). Therefore, the most effective way in
recognition of ischemia is to check the limb (JAB insertion site) for the presence of a
peripheral pulse.
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Patient confidentiality was maintained by assigning individual ID numbers that
will specify the patient and the site. The letters A-D designate the four clinical centers
specified in section 3.1. The sponsor, Datascope Corporation, was given access to the
research data but patient-related information was kept in a confidential portfolio at the
designated site of IABP support. The same holds true for data presented in this study.
Included in Appendix B is data represented with ID numbers and will not include
personal patient profiles.

A.3 Equipment and software
A.3.1 Equipment
The IAB catheter (Datascope Percor STAT-DL 9.5 40 cc) was connected to a Datascope
System 95 IABP console and interfaced with a digital tape recorder (TEAC RD-111T
PCM recorder) for simultaneous recording of the ECG, aortic blood pressure, IAB
pressure waveform and timing signals. Patient ECG and aortic blood pressure were
monitored via the central lumen of the catheter and input into the IABP console.
Data was recorded at the four pre-determined timing points as well as at the
pump-off condition (i.e. "standby"). The pump-off condition is considered a baseline
whereby results of the deflation timing points, particularly, hemodynamic data
representing efficiency, can be compared.

A.3.2 Software utilized for Data Acquisition
A P.C. data acquisition package, CODAS™, was utilized in this study to record the
following signals on the respective channel numbers. Prior to initiation of data
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acquisition, the software was calibrated by placing a 1-volt direct current signal at each of
the input channels and observing 1-volt at each of the output channels through the
CODAS™ software.
Table 2 Signals recorded with CODAS ™

software

APPENDIX B
CALCULATED HEMODYN IC DATA
B.1 Introduction

Hemodynamic data values were obtained from each cardiac cycle during data reduction
(Chapter 4) and were then utilized for further analysis. The subsequent columns are
listed as they appear in the Excel spreadsheets. The Excel spreadsheets are numerous in
volume and therefore, could not all be included as part of this Appendix. Instead, one file
will be included as an example.
Columns A through I pertain to the raw hemodynamic data extracted during data
reduction and Columns J through U pertain to the calculated hemodynamic data. The
term "assisted" refers to data obtained while the IABP is in the pump-on state while
"unassisted" refers to data obtained while the IABP is in the pump-off state. Data is
presented in graphical form and is presented for each patient file in this Appendix.

Column A "Timing ID" identifies the IABP timing setting (e.g. standby, T1, etc.)
Column B"Time (sec)" identifies the time of the R-wave trigger (in seconds) of the

analyzed cardiac cycle relative to the beginning of the recorded file.
Column C "HR (BPM)" identifies the calculated heart rate in beats per minute.
Equation: HR = 60/R-R
(R-R is obtained from Column D)
Column D "R-R (sec)" is the measured time interval (in seconds) between R wave

triggers for a cardiac cycle obtained from the CODAS files, specifically,
the interval between the RSmax of one cardiac cycle.
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Column E

"LVET (sec)" identifies the left ventricular ejection time interval which
initiates from the point of RS,. to the dicrotic notch.

Column F

"DTI (sec)" identifies the diastolic time interval from the dicrotic notch to
RS max.

Column G

"MSAP (mmHg)" defines the mean systolic aortic pressure which is the
area under the curve during the LVET period.

Column H

"MDAP (mmHg)" defines the mean diastolic aortic pressure which is the
area under the curve during the DTI period.

Column I

"MAP (mmHg)" defines the mean aortic pressure which is the area under
the curve during the R-R interval.

Column J

"SPTI (sec)" defines the systolic pressure time index which is an
indication of oxygen demand needed by the heart.

Equation: SPTI = MSAP*LVET
(SPTI is obtained from Column G multiplied by Column E)
Column K

"DPTI/SPTI-assisted (sec)" defines the diastolic pressure time index
divided by the systolic pressure time index which is an indication of
myocardial oxygen supply to oxygen demand ratio.

Equation: DPTI/SPTI = (MDAPVTI)/(MSAP*LVET)
DPTI/SPTI = (Column 11* Column F)/(Column G* Column E)
Column L

"% Change (uncorrected)" is the change in the oxygen supply to oxygen
demand ratio prior to IABP therapy as compared to the ratio after therapy.
The "uncorrected" value is the value obtained prior to the correction made
for pressure or heart rate (see above section for details) and is calculated
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using the mean value in column K (for each timing setting) as compared to
the mean value in column K for "standby".
Equation: % Change = ((Mean DPTI/SPTITC — can DPTI/SPTIstandby)/
DPTI/SPTIstandb y ) * 100

% Change= ((Column K40TC - Column K4Ostandby)/ Column K40Standby)

Columns N-S: Using the "standby" data (baseline), graphs were generated to
determine the effect of heart rate and mean aortic pressure on diastolic and systolic
intervals. There is a strong correlation between heart rate and mean aortic pressure on
these intervals which demonstrate that even with the IABP turned off, these variables are
dynamic (i.e. both heart rate and mean aortic pressure change with time). Thus, it is
critical to take this into account when analyzing the data. The following columns have
been generated based on these graphs with the substitution of the raw hemodynamic data
(Columns E-K) into the linear regression equations. Results and discussion of all
evaluated files are included in Chapter 4 as well as this Appendix.

Column N"LVET (calc)" is defined as the calculated left ventricular ejection time,

which takes into account the effect of heart rate on the systolic interval.
Equation: LVET (calc) is found as follows:

Use linear equation from the graph labeled "Effect of Heart Rate on
Systolic & Diastolic Intervals" which represents a plot of heart rate
versus systolic interval. For each cell in Excel, substitute each heart rate
value from Column C for the x-value in this equation. These calculated
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values take into effect the change in systolic time intervals due to a change
in heart rate.
Column 0"MSAP (calc)" is defined as the calculated mean systolic aortic pressure.
The equation explained below demonstrates the relationship between
mean aortic pressure and mean systolic pressure.

Equation: MSAP (talc) is found as follows:
Use linear equation from the graph labeled "Effect of Mean A©P on
Systolic & Diastolic AoP" which represents a plot of mean aortic pressure
versus mean systolic pressure. For each cell in Excel, substitute each
mean aortic pressure value from Column Ifor the x-value in this equation.
These calculated values take into effect the relationship between total
mean aortic pressure and mean systolic pressure.
Column P"DTI (talc)" is defined as the calculated diastolic mean interval, which
takes into account the effect of heart rate on the diastolic time interval.
Equation: DTI (talc) is found as follows:

Use the linear equation from the graph labeled "Effect of Heart Rate on
Systolic & Diastolic Intervals" which represents a plot of heart rate
versus diastolic time interval. For each cell in Excel, substitute each heart
rate value from Column C for the x-value in this equation. These
calculated values take into effect the change in diastolic time intervals due
to a change in heart rate.
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Column Q

"MDAP (calc)" is defined as the calculated mean diastolic aortic pressure.
The equation explained below demonstrates the relationship between
mean aortic pressure and mean diastolic pressure.

Equation: MDAP (calc) is found as follows:
Use linear equation from the graph labeled "Effect of Mean AoP on
Systolic & Diastolic AoP" which represents a plot of mean aortic pressure
versus mean diastolic pressure. For each cell in Excel, substitute each
mean aortic pressure value from Column Ifor the x-value in this equation.
These calculated values take into effect the relationship between total
mean aortic pressure and mean diastolic pressure.
Column R

"SPTI (calc)" is defined as the calculated mean systolic pressure time
index. The equation explained below demonstrates the effect of change in
heart rate and change in mean pressure.

Equation: SPTI (calc) = L VET (calc) * MSAP (calc)
SPTI (calc) = Column 0 * Column N
Column S

"DPTI/SPTI (calc)" is defined as the calculated index that gives an
indication of oxygen supply versus oxygen demand. The equation
explained below demonstrates the effect of change in heart rate and
change in mean pressure.

Equation: DPTI/SPTI (calc) = (MDAP (calc) * DTI (calc))/(LVET (calc) * MSAP
(calc))
DPTI/SPTI (calc) = (Column Q * Column P)/(Column Q * Column N)
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Column T

"Corr. % Change" is defined as the percent change in calculated index that
gives an indication of oxygen supply versus oxygen demand, defined as
the ratio of DPTI to SPTI. The equation explained below demonstrates the
effect of change in heart rate and change in mean pressure.

Equation: Corr. % Change (calc) = ((DPTI/SPTI (talc) assisted - DPTI/SPTI
(talc) unassisted / DPTI/SPTI (talc) unassisted) *100
Corr. % Change (talc) = ((Column K - Column S)/(Column S)) * 100
Column U "Corr. % Change" is defined as the percent change in the calculated index
that gives an indication of oxygen demand, defined as SPTI. The equation
explained below demonstrates the effect of change in heart rate and
change in mean pressure.
Equation:

Corr. % Change (talc) = ((SPTI (talc) assisted - SPTI (talc) unassisted /
SPTI (talc) unassisted) *100
Corr. % Change (talc) = ((Column J Column R)/(Column R)) * 100
-

B.3 Graphical Representation of Hemodynamic Data
The attached graphs were generated using Excel. There are four graphs presented for
each patient's file and are titled below. Analysis and discussion are included in Chapter
4. The first three graphs include data acquired when the intra-aortic balloon pump was in
the "standby" state and thus, represent patients' hemodynamics prior to IABP support.
The fourth graph provides a comparison of pressure efficacy for each of the deflation
timing points tested. It also compares the correlation factor associated with the original
analysis (generated in the study conducted by Kern et al), uncorrected analysis (analyzed
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using Rsmax to define systole, but not corrected for pressure and heart rate), and
corrected analysis (correcting the "uncorrected" analysis for pressure and heart rate).
•

Effect of Heart Rate on Systolic & Diastolic Intervals

•

Effect of Mean Aortic Pressure (MAP) on Systolic & Diastolic Aortic Pressure

•

Comparison of Calculated & Actual DPTI/SPTI

•

Pressure Efficacy vs. Deflation Timing-Original, Uncorrected, & Corrected
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The graphs below indicate the correlation between heart rate and pressure. They are
further explained in Chapter 4.

Figure 1B

Figure 2B

69

Figure 3B

Figure 4B

70

Figure 5B

Figure 6B

71

Figure 7B

Figure 8B

72

Figure 9B

Figure 10B

73

Figure 11B

Figure 12B

74

Figure 13B

Figure 14B

75

Figure 15B

Figure 16B

76

Figure 1713

Figure 18B

77

Figure 19B

Figure 20B

78

Figure 21B

Figure 22B

79

Figure 23B

Figure 24B

80

Figure 25B

Figure 26B

81

Figure 27B

Figure 28B

82

Figure 29B

Figure 30B

83

Figure 31B

Figure 32B

84

Figure 33B

Figure 34B

85

Figure 35B

Figure 36B

86

Figure 37B

Figure 38B

87

Figure 39B

Figure 40B

88

Figure 41B

Figure 42B

89

Figure 43B

Figure 44B

90

Figure 45B

Figure 46B

91

Figure 47B

Figure 48B

92

Figure 49B

Figure 50B

93

Figure 51B

Figure 52B

94

Figure 53B

Figure 54B

95

Figure 55B

Figure 56B

96

Figure 57B

Figure 58B

97

Figure 59B

Figure 60B

98

Figure 61B

Figure 62B

99

Figure 63B

Figure 64B

1 00

Figure 65B

Figure 66B

101

Figure 67B

Figure 68B

102

Figure 69B

Figure 70B

103

Figure 71B

Figure 72B

104

Figure 73B

Figure 74B

105

Figure 75B

Figure 76B

106

Figure 77B

Figure 78B

107

Figure 79B

Figure 80B

APPENDIX C
SUMMARY OF DATA
In this Appendix, a summary of all the patients' files analyzed is provided. Refer
to Chapter 5 for explanation of each of the hemodynamic indices calculated.

Figure 1C
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